Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Non-cash Items (2019 - 2025)

Lipocine (LPCN) has disclosed Non-cash Items for 8 consecutive years, with $262754.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-cash Items rose 1910.51% year-over-year to $262754.0, compared with a TTM value of $262754.0 through Sep 2025, up 1910.51%, and an annual FY2024 reading of $440000.0, up 126.54% over the prior year.
  • Non-cash Items was $262754.0 for Q3 2025 at Lipocine, up from $256738.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $2.9 million in Q4 2022 and bottomed at $4586.0 in Q2 2023.
  • Average Non-cash Items over 5 years is $1.4 million, with a median of $440000.0 recorded in 2024.
  • The sharpest move saw Non-cash Items soared 17077.12% in 2021, then plummeted 99.83% in 2023.
  • Year by year, Non-cash Items stood at $2.8 million in 2021, then increased by 3.91% to $2.9 million in 2022, then tumbled by 93.32% to $194228.0 in 2023, then skyrocketed by 126.54% to $440000.0 in 2024, then tumbled by 40.28% to $262754.0 in 2025.
  • Business Quant data shows Non-cash Items for LPCN at $262754.0 in Q3 2025, $256738.0 in Q2 2025, and $244926.0 in Q1 2025.